期刊文献+

食管癌放疗患者T淋巴细胞和自然杀伤细胞水平的临床研究 被引量:3

Clinical research on expression levels of T lymphocytes and NK cells in patients with esophagealcancer treated with radiotherapy
原文传递
导出
摘要 目的 探讨行放疗的食管癌患者外周血T淋巴细胞、自然杀伤(NK)细胞的变化及其与放疗疗效的相关性.方法 对56例经病理组织学确诊的食管癌患者采用单纯放疗,应用流式细胞术测定其治疗前后外周血T淋巴细胞亚群及NK细胞比例,评价其与近、远期治疗效果的相关性.以30名健康体检者外周血为健康对照.结果 食管癌患者外周血T细胞比例、Th细胞比例、Th/Ts分别为( 58.3±5.2)%、(28.7±5.0)%、1.0±0.3,低于健康对照组的(65.8±7.2)%、(38.1±7.7)%、1.6±0.7(均P< 0.05);而Ts细胞比例为(28.8±5.3)%,高于健康对照组的(25.4±5.7)%(P<0.05).外周血T淋巴细胞亚群及Th/Ts的变化与患者性别、肿瘤分期、病理分化程度、病变部位等临床病理参数之间的差异均无统计学意义(均P> 0.05).放疗后,患者外周血总T细胞比例、Th细胞比例、Th/Ts及NK细胞比例分别为( 66.9±4.5)%、(40.6±5.6)%、(1.6±0.5)%和(16.2±3.9)%,均高于治疗前的(59.4±4.9)%、( 29.1±4.2)%、(1.0±0.4)%和(14.6±3.2)%(均P< 0.05),而Ts细胞比例治疗后为(25.4±3.6)%,较治疗前的( 28.4±5.7)%降低(P<0.05).总T细胞、Th细胞增高程度与病变进展密切相关,差异有统计学意义(均P< 0.05).结论 T淋巴细胞亚群、NK细胞可用于行放疗的食管癌患者的免疫监测.检测患者外周血相关指标的表达对评估患者的免疫功能。 Objective To study the relationship between the change of T lymphocyte subsets and NK cells in esophageal cancer patients and radiotherapy effect.Methods The levels of T lymphocyte subsets and NK cells were detected by flow cytometry in 56 cases with histologically confirmed esophageal cancer treated with radiotherapy and contrasted to the healthy people.Results In patients with esophageal cancer,peripheral blood T cells,Th cells,Th / Ts were decreased significantly compared with the control group [(58.3±5.2) % vs (65.8±7.2) %,(28.7±5.0) % vs (38.1±7.7) %,(1.0±0.3) vs (1.6+2.7),all P 〈 0.05],while the Ts cells were significantly increased [(28.8±5.3) % vs (25.4±5.7) %,P 〈 0.05].There was no significant difference between peripheral blood T lymphocyte subsets,Th/Ts ratio change and patient age,sex,tumor staging,histological differentiation and pathological lesions.After radiotherapy,the levels of peripheral blood T cells,Th cells,Th/Ts cell ratio and NK cells in esophageal cancer patients were increased [(66.9±4.5) % vs (59.4±4.9) %,(40.6±5.6) % vs (29.1±4.2) %,(1.6+0.5) % vs (1.0±0.4) %,(16.2±3.9) % vs (14.6±3.2) %,all P 〈 0.05],while the Ts cells decreased [ (25.4±3.6) % vs (28.4±5.7) %,P 〈 0.05].The increasing degree of peripheral blood T cells,Th cells were closely related to the lesion progress,the difference was significant (both P 〈 0.05).Conclusion Cellular immune function in patients with esophageal cancer is low.Detection of T lymphocyte subsets,NK cells can be used for immune monitoring of patients with esophageal cancer
出处 《肿瘤研究与临床》 CAS 2011年第10期674-677,共4页 Cancer Research and Clinic
基金 连云港市卫生局课题(C320)
关键词 食管肿瘤 T淋巴细胞亚群 杀伤细胞 天然 放射疗法 Esophageal neoplasms T lymphocyte subsets Killer cells, natural Radiotherapy
  • 相关文献

参考文献10

二级参考文献21

  • 1李晓洲,陈复兴,姚仁南,黄晓静,朱月蓉,吕杭,骆晓梅.全血细胞计数仪测定指数对肝病的诊断价值[J].肝脏,1998,3(4):60-61. 被引量:2
  • 2范圣登,徐骅,丁洁,卜晓萱,李琼,邱国强,沈志忠.输血对肠癌患者围术期细胞免疫功能的影响[J].江苏医药,2005,31(8):573-575. 被引量:9
  • 3王凤安,罗玉贤,闫庆辉,刘津,张国建,蔡建辉,薛平.大肠癌中肿瘤坏死因子相关凋亡诱导配体及其影响因子表达的研究[J].中华实验外科杂志,2006,23(2):253-253. 被引量:2
  • 4[1]Hemberg M.Lymphocyte subset as.prognostic markers for cancer patients receiving immunomodul ative therapy[J].Med oncol,1999,16(3):145.
  • 5[2]Hong C,Lee H,Oh M,Kang CY,Hong S,Park SH.CD4+ T cells in the absence of the CD8+cytotoxic T cells are critical and sufficient for NKT cell-dependent tumor rejection[J].J lmmunol,2006 Nov 15;177(1 01:6747~6777.
  • 6[4]Grossmann I,de Bock GH,Meershoek-Klein Kranenbarg WM,vande Velde CJ,Wiggem T Carcinoembryonic antigen(CEA)measurement during follow-up for rectal c.arcinonla is useful even if normal levels exist before surgery.A retrospective study of CEA values in the TME trial[J].Eur J Surg Oncol,2007 Mar,33(2):183~187.
  • 7[5]Sica A,Saccani A,Bottazzi B,et al.Autocrine production of IL-10 mediates defective IL-12 production and NF-kappa B activation in tumor-associated macrophages[J].J Immunol,2000,164(2):762~767.
  • 8[6]Koehler H,Kofler D,Hombach A,Abken H.CD28 costimulation overcomes transforming growth factor-beta-mediated repression of proliferation of redirected human CD4+ and CD8+ T cells in an antitumor cell attack[J].Cancer Res,2007 Mar 1,67(5):2265~2273.
  • 9Tsukishiro T,Donnenberg AD,Whiteside TL.Rapid turnover of the CD8^+ CD28^+ T-cell subset of effector cells in the circulation of patients with head and neck cancer[J].Cancer Immunol Immunother,2003,52(10):599-607.
  • 10Kay NE,Leong TL,Bone N,et al.Blood levels of immune cells predict survival in myeloma patients:results of an Eastern Cooperative Oncology Group Phase 3 trial for newly diagnosed multiple myeloma patients[J].Blood,2001,98(1):23-28.

共引文献76

同被引文献18

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部